Literature DB >> 6859037

Absence of cross-reacting material in isolated propionyl CoA carboxylase deficiency: nature of residual carboxylating activity.

F Kalousek, M D Orsulak, L R Rosenberg.   

Abstract

Fibroblast extracts and fetal liver homogenates from patients with propionic acidemia due to inherited deficiency of propionyl CoA carboxylase (PCC) were analyzed for the presence of immunologically cross-reactive PCC protein. Using several rabbit antisera raised against homogeneous human liver PCC, homogeneous pig heart PCC, or the individual non-identical subunits of the human liver enzyme, we found no detectable cross-reacting material by direct or competitive immunotitration in several cell lines from patients in either major complementation group (pcc A; pcc C) with isolated PCC deficiency. In contrast, cells of a patient from the bio complementation group contained normal amounts of immunoreactive PCC. Further analysis of the pcc A and pcc C mutants revealed that their residual propionyl CoA carboxylating activity varied greatly depending on the concentration of extract or homogenate protein used in the PCC assay. When propionyl CoA carboxylation was assayed at high protein concentration in a fetal liver homogenate from a pcc C patient, the apparent PCC activity was comparable to that found in normal human fetal liver. Significantly, the specific activity in the mutant, but not in the control, extract declined steeply as protein concentration was lowered, and this loss could not be prevented by adding PCC substrates, bovine serum albumin, glycerol, or 2-mercaptoethanol. Moreover, detailed analyses of immunotitration curves of control fibroblasts extracts showed that fresh extracts contained an amount of nonimmunotitratable carboxylating activity corresponding to the residual activity present in fresh extracts of mutant cell lines. We conclude that the residual propionyl CoA carboxylating activity found in isolated PCC deficiency represents another carboxylase that can utilize propionyl CoA as a substrate rather than a mutant form of PCC with markedly different immunochemical and physicochemical properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859037      PMCID: PMC1685634     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Genetic complementation of propionyl-CoA carboxylase deficiency in cultured human fibroblasts.

Authors:  R A Gravel; K F Lam; K J Scully; Y Hsia
Journal:  Am J Hum Genet       Date:  1977-07       Impact factor: 11.025

2.  Localisation of enzymic defect in propionicacidaemia.

Authors:  D Gompertz; C N Storrs; D C Bau; T J Peters; E A Hughes
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

3.  Defective propionate carboxylation in ketotic hyperglycinaemia.

Authors:  Y E Hsia; K J Scully; L E Rosenberg
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

4.  Propionic acidemia: diagnosis by enzyme assay in frozen leukocytes.

Authors:  Y E Hsia; K J Scully
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

5.  Inherited propionyl-Coa carboxylase deficiency in "ketotic hyperglycinemia".

Authors:  Y E Hsia; K J Scully; L E Rosenberg
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

6.  Propionic acidemia in patients with ketotic hyperglycinemia.

Authors:  T Ando; K Rasmussen; W L Nyhan; G N Donnell; N D Barnes
Journal:  J Pediatr       Date:  1971-05       Impact factor: 4.406

7.  Combined carboxylase defect: biotin-responsiveness in cultured fibroblasts.

Authors:  K Bartlett; D Gompertz
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

8.  Biochemical differences between mutant propionyl-CoA carboxylases from two complementation groups.

Authors:  B Wolf; Y E Hsia; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

9.  Human propionyl CoA carboxylase: some properties of the partially purified enzyme in fibroblasts from controls and patients with propionic acidemia.

Authors:  Y E Hsia; K J Scully; L E Rosenberg
Journal:  Pediatr Res       Date:  1979-06       Impact factor: 3.756

10.  Deficiency of propionyl-Co A carboxylase and methylcrotonyl-Co A carboxylase in a patient with methylcrotonylglycinuria.

Authors:  W Weyler; L Sweetman; D C Maggio; W L Nyhan
Journal:  Clin Chim Acta       Date:  1977-05-02       Impact factor: 3.786

View more
  2 in total

1.  Assignment of the alpha and beta chains of human propionyl-CoA carboxylase to genetic complementation groups.

Authors:  A M Lam Hon Wah; K F Lam; F Tsui; B Robinson; M E Saunders; R A Gravel
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

2.  The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency.

Authors:  B H Robinson; J Oei; W G Sherwood; D Applegarth; L Wong; J Haworth; P Goodyer; R Casey; L A Zaleski
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.